Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate Arcellx Inc before investing.

In this article, we go over a few key elements for understanding Arcellx Inc’s stock price such as:

• Arcellx Inc’s current stock price and volume
• Why Arcellx Inc’s stock price changed recently
• Upgrades and downgrades for ACLX from analysts
• ACLX’s stock price momentum as measured by its relative strength

About Arcellx Inc (ACLX)

Before we jump into Arcellx Inc’s stock price, history, target price and what caused it to recently dip, let’s take a look at some background.

Arcellx, Inc. is a clinical-stage biotechnology company. The Company is focused on the development of controllable cell therapies for the treatment of patients with cancer and other incurable diseases. The Company’s lead program is a BCMA-targeting ddCAR product candidate called CART-ddBCMA, which is being evaluated in its pivotal Phase II iMMagine-1 trial in patients with relapsed or refractory multiple myeloma (rrMM). The Company is also developing two clinical-stage ARC-SparX programs in Phase I trials; ACLX-001, which targets BCMA in rrMM, and ACLX-002, which targets CD123 in relapsed or refractory acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome (MDS). Outside of multiple myeloma (MM), the Company advances its wholly owned portfolio of clinical-stage, ACLX-002, and preclinical pipeline programs incorporating its D-Domain technology. D-Domain, is designed to overcome the limitations of traditional Chimeric Antigen Receptor T-cells (CAR-Ts).

Want to learn more about Arcellx Inc’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about Arcellx Inc.

Arcellx Inc’s Stock Price as of Market Close

As of August 02, 2024, 4:00 PM, CST, Arcellx Inc’s stock price was $55.31.

Arcellx Inc is down 5.69% from its previous closing price of $58.65.

During the last market session, Arcellx Inc’s stock traded between $58.27 and $61.98. Currently, there are 52.76 million shares of Arcellx Inc stock available for purchase.

Unfortunately, Arcellx Inc’s P/E ratio is not significant enough to use for stock price evaluation. We recommend investors evaluate other financial metrics to understand its overall valuation.

Arcellx Inc Stock Price History

Arcellx Inc’s (ACLX) price is currently down 10.52% so far this month.

During the month of August, Arcellx Inc’s stock price has reached a high of $61.98 and a low of $53.46.

Over the last year, Arcellx Inc has hit prices as high as $75.10 and as low as $30.88. Year to date, Arcellx Inc’s stock is up 78.53%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused Arcellx Inc Stock’s Price to Dip?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of August 01, 2024, there was 1 analyst who downgraded Arcellx Inc’s stock and 1 analyst who upgraded over the last month.

Additionally, you'll want to evaluate Arcellx Inc’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on Arcellx Inc’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

Arcellx Inc’s current valuation based on AAII’s Value Grade is a F, which means it is considered to be Ultra Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about Arcellx Inc (ACLX) by visiting AAII Stock Evaluator.

Relative Price Strength of Arcellx Inc

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of August 01, 2024, Arcellx Inc has a weighted four-quarter relative price strength of 10.23%, which translates to a Momentum Score of 89 and is considered to be Very Strong.

Want to learn more about how Arcellx Inc is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

Arcellx Inc Stock Price: Bottom Line

As of August 2, 2024, Arcellx Inc’s stock price is $55.31, which is down 5.69% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like Arcellx Inc stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.